SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-062821
Filing Date
2023-05-19
Accepted
2023-05-19 20:44:37
Documents
1
Period of Report
2022-04-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2316214-9_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2316214-9_4aseq1.xml 4/A 6384
  Complete submission text file 0001104659-23-062821.txt   7878
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAGUAR HEALTH INC., 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address
Chaturvedi Pravin R (Reporting) CIK: 0001916935 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36714 | Film No.: 23942180